Our Mission

Evaluate novel biologic agents in breast cancer patients to help find new treatments. Recent work has focused on the intrinsic therapy resistance of cancer stem cells, especially the role of inducible nitric oxide signaling in chemoresistance and metastasis.

Jenny C. Chang, MD

Emily Herrmann Chair in Cancer Research & Director, Cancer Center
Professor of Medicine in Oncology, Academic Institute
Full Member, Research Institute
Houston Methodist
Weill Cornell Medical College

Jenny C. Chang, MD is the Director of Houston Methodist Cancer Center and Emily Herrmann Chair in Cancer Research in Houston, Texas. She obtained her medical degree at Cambridge University in England, and then completed fellowship training in medical oncology at the Royal Marsden Hospital/Institute for Cancer Research in the United Kingdom. She was also awarded a research doctorate from the University of London.

0
Citations
0
H-Index
0
Research Outputs